Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Network Covalent Solids

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and validation of a self-management efficacy questionnaire for patients with Fabry disease in China.

Annals of medicine·2026

Same author

Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease.

Journal of inflammation research·2025

Same author

Low-Dose Iron and Early Development in Breastfed Infants.

JAMA pediatrics·2024

Same author

Radiological and histopathological features of short rib‑polydactyly syndrome type III and identification of two novel <i>DYNC2H1</i> variants.

Molecular medicine reports·2021

Same author

Penalized logistic regression based on L1/2 penalty for high-dimensional DNA methylation data.

Technology and health care : official journal of the European Society for Engineering and Medicine·2020

Same author

MicroRNA-144 Regulates Cardiomyocyte Proliferation and Apoptosis by Targeting TBX1 through the JAK2/STAT1 Pathway.

Cytogenetic and genome research·2020

Search research articles

Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

The L_1/2 regularization network Cox model for analysis of genomic data.

Hong-Kun Jiang¹, Yong Liang¹

¹Faculty of Information Technology & State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, 999078, China.

Computers in Biology and Medicine

|July 23, 2018

Summary

This study introduces a network-based L1/2 penalty method for Cox proportional hazards models in survival analysis. It improves predictive accuracy by integrating gene regulatory network information, leading to more relevant gene selections for cancer research.

Keywords:

Cox proportional hazards model L(1/2) penalty Network

More Related Videos

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Published on: June 28, 2018

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Related Experiment Videos

Last Updated: Feb 7, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Published on: June 28, 2018

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Area of Science:

Genomics
Bioinformatics
Biostatistics

Background:

Variable selection in Cox proportional hazards models is crucial for survival analysis.
Existing methods often overlook valuable regulatory network and pathway information.
Integrating prior biological pathway knowledge can enhance genomic data analysis.

Purpose of the Study:

To develop a network-based regularization method for the L1/2 penalty.
To apply this method to high-dimensional survival analysis, incorporating pathway information.
To improve gene selection and predictive accuracy in cancer research.

Main Methods:

Proposed a novel network-based regularization approach for the L1/2 penalty.
Utilized an L1/2 regularized solver combined with network information.
Penalized the Cox proportional hazards model for coefficient sparsity and network smoothness.

Main Results:

Achieved higher predictive accuracy compared to previous methods in simulations and real breast cancer data.
Selected fewer genes, but these showed stronger associations with cancer.
Validated findings using GeneCards for biological relevance.

Conclusions:

The proposed network-based L1/2 penalty method effectively integrates pathway information into survival analysis.
This approach enhances predictive accuracy and identifies more biologically relevant genes.
The method offers a promising tool for high-dimensional genomic data analysis in cancer research.